Mailman, Richard B.

Third Generation Antipsychotic Drugs: Partial Agonism or Receptor Functional Selectivity?

Mailman, R., & Murthy, V. (2010) · Current Pharmaceutical Design

Schizophrenia research and treatmentReceptor Mechanisms and Signaling

Cited by 311

Task specific influences of Parkinson’s disease on the striato-thalamo-cortical and cerebello-thalamo-cortical motor circuitries

Lewis, M. M., Slagle, C. G., Smith, A. B., Truong, Y., Bai, P., McKeown, M. J., Mailman, R. B., Belger, A., & Huang, X. (2007) · Neuroscience

Parkinson's Disease Mechanisms and TreatmentsDeep Brain Stimulation and Movement Disorders

Cited by 148

Low LDL cholesterol and increased risk of Parkinson's disease: Prospective results from Honolulu‐Asia Aging Study

Huang, X., Abbott, R. D., Petrovitch, H., Mailman, R. B., & Ross, G. W. (2008) · Movement Disorders

Parkinson's Disease Mechanisms and TreatmentsNuclear Receptors and Signaling

Cited by 124

Functional selectivity of dopamine receptor agonists. I. Selective activation of postsynaptic dopamine D2 receptors linked to adenylate cyclase

Mottola, D. M., Kilts, J. D., Lewis, M. M., Connery, H. S., Walker, Q. D., Jones, S. R., Booth, R. G., Hyslop, D. K., Piercey, M., Wightman, R. M., et al. (2002) · The Journal of Pharmacology and Experimental Therapeutics

Receptor Mechanisms and SignalingNeurotransmitter Receptor Influence on Behavior

Cited by 123

Higher iron in the red nucleus marks Parkinson's dyskinesia

Lewis, M. M., Du, G., Kidacki, M., Patel, N., Shaffer, M. L., Mailman, R. B., & Huang, X. (2013) · Neurobiology of Aging

Parkinson's Disease Mechanisms and TreatmentsNeurological diseases and metabolism

Cited by 84